Skip to main content
TipRanks
Go Ultimate75% OFF

Vaxxinity Inc (VAXX) Ratios

144 Followers

Vaxxinity Inc Ratios

VAXX's free cash flow for Q4 2023 was $-12.26M. For the 2023 fiscal year, VAXX's free cash flow was decreased by $-414.00K and operating cash flow was $-11.85M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 23Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio1.893.035.610.960.07
Quick Ratio1.892.845.610.870.07
Cash Ratio0.281.085.270.840.02
Solvency Ratio0.07-1.66-3.58-0.29-0.28
Operating Cash Flow Ratio-3.25-1.81-2.95-0.91-0.62
Short-Term Operating Cash Flow Coverage-30.03-37.19-215.40-1.23-0.93
Net Current Asset Value$ 2.33M$ 49.66M$ 116.08M$ -101.84M$ -48.67M
Leverage Ratios
Debt-to-Assets Ratio0.340.140.060.768.99
Debt-to-Equity Ratio1.130.230.08-0.44-0.30
Debt-to-Capital Ratio0.530.190.08-0.78-0.42
Long-Term Debt-to-Capital Ratio0.500.170.07-0.14-0.02
Financial Leverage Ratio3.301.711.30-0.57-0.03
Debt Service Coverage Ratio-20.75-36.18-111.21-1.32-1.00
Interest Coverage Ratio-83.74-147.82-148.90-27.33-31.40
Debt to Market Cap0.140.080.020.020.01
Interest Debt Per Share0.130.120.090.310.12
Net Debt to EBITDA-0.190.260.99-0.19-1.02
Profitability Margins
Gross Profit Margin0.00%0.00%-2834.85%90.66%0.00%
EBIT Margin0.00%0.00%-206568.18%-6961.40%0.00%
EBITDA Margin0.00%0.00%-204898.48%-6832.68%0.00%
Operating Profit Margin0.00%0.00%-189507.58%-5795.69%0.00%
Pretax Profit Margin0.00%0.00%-207840.91%-7173.61%0.00%
Net Profit Margin0.00%0.00%-207840.91%-7173.61%0.00%
Continuous Operations Profit Margin0.00%0.00%-207840.91%-7173.61%0.00%
Net Income Per EBT100.00%99.98%100.00%100.00%100.40%
EBT Per EBIT0.10%99.00%109.67%123.77%103.67%
Return on Assets (ROA)-0.13%-70.69%-82.30%-79.69%-891.47%
Return on Equity (ROE)-0.42%-120.96%-106.65%45.73%29.31%
Return on Capital Employed (ROCE)-218.25%-100.69%-89.87%-249.92%74.73%
Return on Invested Capital (ROIC)-203.71%-98.71%-89.62%-79.69%268.13%
Return on Tangible Assets-0.13%-70.69%-82.30%-79.69%-891.47%
Earnings Yield-0.05%-42.66%-19.50%-1.92%-0.68%
Efficiency Ratios
Receivables Turnover0.000.000.171.440.00
Payables Turnover1.250.320.610.010.08
Inventory Turnover0.000.270.000.020.00
Fixed Asset Turnover0.000.000.010.050.00
Asset Turnover0.000.000.000.010.00
Working Capital Turnover Ratio0.000.000.00-0.060.00
Cash Conversion Cycle-291.31179.681571.92-39819.19-4380.00
Days of Sales Outstanding0.000.002173.41253.600.00
Days of Inventory Outstanding0.001327.350.0023247.690.00
Days of Payables Outstanding291.311147.67601.4963320.484380.00
Operating Cycle0.001327.352173.4123501.290.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.45-0.44-0.65-0.27-0.10
Free Cash Flow Per Share-0.46-0.46-0.66-0.28-0.10
Dividend Paid and CapEx Coverage Ratio-71.28-29.97-61.45-22.960.00
Capital Expenditure Coverage Ratio-71.28-29.97-61.45-22.960.00
Operating Cash Flow Coverage Ratio-3.77-3.84-7.57-0.89-0.86
Operating Cash Flow to Sales Ratio0.000.00-1227.12-60.880.00
Free Cash Flow Yield-53.98%-32.78%-11.70%-1.70%-0.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1888.72-2.34-5.13-51.96-146.02
Price-to-Sales (P/S) Ratio0.000.0010658.343727.560.00
Price-to-Book (P/B) Ratio8.022.845.47-23.76-42.80
Price-to-Free Cash Flow (P/FCF) Ratio-1.85-3.05-8.55-58.67-169.28
Price-to-Operating Cash Flow Ratio-1.88-3.15-8.69-61.23-169.28
Price-to-Earnings Growth (PEG) Ratio18.900.05-0.02-0.270.00
Enterprise Value Multiple-2.18-2.16-4.21-54.74-153.90
Enterprise Value117.77M157.39M569.26M2.08B2.09B
EV to EBITDA-2.18-2.16-4.21-54.74-153.90
EV to Sales0.000.008625.223740.420.00
EV to Free Cash Flow-2.03-2.72-6.92-58.88-170.41
EV to Operating Cash Flow-2.06-2.81-7.03-61.44-170.41
Tangible Book Value Per Share0.110.491.03-0.70-0.39
Shareholders’ Equity Per Share0.110.491.03-0.70-0.39
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00-0.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.00-0.60-1.09-0.32-0.11
Tax Burden1.001.001.001.001.00
Interest Burden0.001.011.011.031.03
Research & Development to Revenue0.000.001081.5036.930.00
SG&A to Revenue0.000.00785.2321.930.00
Stock-Based Compensation to Revenue0.000.00460.791.820.00
Income Quality1.010.740.590.850.86

Currency in USD